Elizabeth Schwartz is the Co-Chair of the SAGE Board of Directors. She has been practicing law since 1997 and is one of Miami’s best-known advocates for the legal rights of the LGBT community.
Kevin Williams, M.D., is the Co-Chair of the SAGE Board of Directors. Williams is the Chief Medical Officer (CMO) for Pfizer Rare Disease. In this role, he leads a Medical Affairs organization of approximately 200 medical colleagues around the globe supporting Pfizer’s efforts and portfolio in Rare Disease.
Michael Burke is the Treasurer and Chair of the Finance Committee for the SAGE Board of Directors. He has had a successful career in organizational and financial management in the nonprofit, government, and private sectors. As the Chief Operating Officer of New York Life’s private foundation, he has operational and financial oversight of the foundation and manages operations and budgeting for the company’s corporate responsibility activities.
Linda Scott is the Secretary and Chair of the Nominating and Governance Committee for the SAGE Board of Directors. She has 20 years of experience in global corporate governance, proxy voting, and engagement. She is a Managing Director and Associate Corporate Secretary at JPMorgan Chase & Co., where she is responsible for outreach to shareholders on corporate governance policies and practices.
Myron Sulzberger Rolfe (“Mickey Rolfe”) is the Chair of the Development Committee. He is President and Foundation Manager of the recently recapitalized and restructured Sulzberger Rolfe Foundation (formerly known as the Edward Sulzberger Foundation Inc.), dedicated to improving the quality of life of all New Yorkers.